product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Plasminogen Antibody (SBF1 C1.21) [Allophycocyanin]
catalog :
NB100-2791APC
quantity :
0.1 ml
price :
499 USD
clonality :
monoclonal
host :
mouse
conjugate :
APC
clone name :
SBF1 C1.21
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NB100-2791APC
SKU :
NB100-2791APC
product name :
Plasminogen Antibody (SBF1 C1.21) [Allophycocyanin]
sizes available :
0.1 ml
description :
The Plasminogen Antibody (SBF1 C1.21) [Allophycocyanin] from NB100-2791APC is a 6.3e-05 antibody to . This antibody reacts with human.
target :
Plasminogen
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
SBF1 C1.21
conjugate :
Allophycocyanin
dilution :
ELISA
host :
Mouse
immunogen :
Human Plasminogen
isotype :
IgG1
purity :
Protein A or G purified
species :
Human
specificity :
Does not cross react with HGF1/MSP or HGF/SF. Cross reacts with plasmin
gene symbol :
PLG
applications :
ELISA
USD :
499 USD
alt names :
DKFZp779M0222, EC 3.4.21, EC 3.4.21.7, plasmin, plasminogen
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Plasminogen Antibody (SBF1 C1.21) [Alexa Fluor™ Plus 680] | NB100-2791AFP680
- Plasminogen Antibody (SBF1 C1.21) [Alexa Fluor™ Plus 647] | NB100-2791AFP647
- OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [PE/Cy7] | NBP2-75913PECY7
- OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [PE/Cy5.5] | NBP2-75913PECY55
- OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [PE/Atto594] | NBP2-75913PEATT594
questions and comments
